Screener
Denali Therapeutics Inc. DNLI Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:08 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001714899-26-000097
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accounts receivable, net | 3,927 | — |
| Inventory | 4,139 | — |
| Prepaid expenses and other current assets | 35,390 | 32,779 |
| Total current assets | 753,927 | 900,658 |
| Long-term marketable securities | 229,534 | 98,322 |
| Property and equipment, net | 49,926 | 52,402 |
| Finance lease right-of-use asset | 46,700 | 48,531 |
| Operating lease right-of-use asset | 16,793 | 19,002 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Denali Therapeutics Inc.'s total current assets?
- Denali Therapeutics Inc. (DNLI) reported total current assets of $753.93M in Q2 2026.
- How has Denali Therapeutics Inc.'s total current assets changed year-over-year?
- Denali Therapeutics Inc.'s total current assets decreased by 19.3% year-over-year, from $934.71M to $753.93M.
- What is the long-term trend for Denali Therapeutics Inc.'s total current assets?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s total current assets has grown at a -9.6% compound annual growth rate (CAGR), from $1.5B to $900.66M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Denali Therapeutics Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude